109 results on '"Munkhaugen J"'
Search Results
2. Treatment patterns and adherence to lipid-lowering drugs during 8 years of follow-up after a cardiovascular event
3. Validation of a novel direct method to determine reduced adherence to atorvastatin therapy
4. Health-related quality of life in outpatients with coronary heart disease: impact of type D personality, depression, anxiety and insomnia
5. Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease
6. Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
7. Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population
8. Worry, rumination and insomnia in patients with coronary heart disease -a cross-sectional study with long-term follow-up
9. Effect of in-hospital nurse-led smoking cessation intervention for patients with atherosclerotic cardiovascular disease: a randomised pilot study
10. Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations
11. Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients
12. Type D personality, cardiovascular risk factors and risk of recurrent major adverse cardiac events in outpatients with coronary heart disease
13. A feasibility study of the Attention Training Technique in a group format for anxiety and depression in outpatients with coronary heart disease
14. Cost-minimisation analysis of acute myocardial infarction rule-out in low-risk patients: primary care emergency setting versus hospital setting
15. Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects
16. High but not low self-reported statin adherence was confirmed by a novel method based on plasma-statin measurements in coronary outpatients
17. A novel direct method to determine adherence to simvastatin therapy in patients with coronary heart disease
18. Challenges in coronary heart disease prevention – experiences from a long-term follow-up study in Norway
19. Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
20. Clinical factors, psychological factors and beliefs about statin use in patients with coronary heart disease and self-perceived muscle side-effects
21. P4398Potentially modifiable clinical and psychosocial factors associated with recurrent cardiovascular events in an outpatient coronary population
22. The effect of atorvastatin on mevalonate levels in blood plasma in patients with coronary heart disease and muscle side effects
23. Cognitive behavioural therapy for insomnia (CBT-I) in patients with coronary heart disease: a protocol for a randomized controlled trial with six months follow-up
24. Statin adherence in coronary outpatients: a novel direct method compared with pharmacy registry data
25. Challenges in coronary heart disease prevention – experiences from a long-term follow-up study in Norway.
26. New aspects of pre-eclampsia: lessons for the nephrologist
27. Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway
28. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
29. Blood pressure reference values in adolescents: methodological aspects and suggestions for Northern Europe tables based on the Nord-Trøndelag Health Study II.
30. Validation of a novel direct method to determine reduced adherence to atorvastatin therapy.
31. Association of normal body mass index and weight loss with long-term major cardiovascular events after PCI for myocardial infarction.
32. Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
33. The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics.
34. A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial.
35. The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study.
36. Editorial: Progress in understanding and treating distress, sleep, and personality in heart and lung disease.
37. Frailty, health literacy and self-care in patients admitted with acute heart failure.
38. Attention training technique delivered in groups as treatment for anxiety and depression in patients with coronary heart disease: study protocol for a waiting-list randomized controlled trial.
39. Psychiatric disorders, rumination, and metacognitions in patients with type D personality and coronary heart disease.
40. Predictors of health-related quality of life in outpatients with coronary heart disease.
41. [PCSK9 inhibitors on reimbursable prescription: who is eligible?].
42. Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms.
43. Risk of recurrent cardiovascular events in coronary artery disease patients with Type D personality.
44. Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study.
45. [E. Sverre et al. respond].
46. Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction.
47. Personalised cardiovascular disease prevention in the new guidelines.
48. Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs.
49. Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting.
50. Relationships between depression, anxiety, type D personality, and worry and rumination in patients with coronary heart disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.